Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration.
CONCLUSION: IL-25R is involved in Th-related mucosal inflammation and proliferation of intestinal stem cells in IBD. IL-25 enhances the capacity of MSC to induce intestinal epithelial cell regeneration, and MSC therapy with IL-25 may be a new direction for IBD treatment.
PMID: 29312486 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Crohn's Disease | Inflammatory Bowel Disease | Research | Stem Cell Therapy | Stem Cells | Study | Ulcerative Colitis